Recently, studies have explored the relationships between IKZF3 and hypoxia-immunity in cervical cancer, which may be beneficial to the development of novel prognostic biomarkers and therapeutic strategies for cervical cancer [55]. This evidence concerns the gene IKZF3 and cervical carcinoma.